Ionis Pharmaceuticals Inc

Ownership Transactions Reported by 22 Insiders

Symbol
IONS on Nasdaq
Location
2855 Gazelle Court, Carlsbad, California

Insiders trading volume in the past year

Ionis Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Brett P. Monia Chief Executive Officer, Director $39.7M -$7.82M -16.5% Aug 30, 2024
Hougen Elizabeth L EVP, Finance & CFO $10.5M -$650K -5.82% Feb 2, 2024
Onaiza Cadoret-Manier EVP,Chf GL Pdt Str & Oper Ofc $7.95M -$493K -5.84% Feb 2, 2024
Richard S. Geary EVP, Chief Development Officer $7.78M -$1.77M -18.5% Aug 30, 2024
Joseph H. Wender Director $6.84M Jul 15, 2024
Eugene Schneider EVP, Chf Clinical Develop Ofcr $6.83M -$2.2M -24.4% Feb 2, 2024
Patrick R. O'neil EVP CLO & General Counsel $6.43M -$1.99M -23.7% Aug 30, 2024
C. Frank Bennett EVP, Chief Scientific Officer $6.34M -$2.97M -31.9% Aug 30, 2024
Spencer R. Berthelsen Director $6.29M -$645K -9.3% Jul 15, 2024
Eric Swayze EVP Research $5.87M -$2.43M -29.3% Aug 30, 2024
Brian Birchler EVP, Corp and Development Ops $4.88M -$264K -5.14% Aug 30, 2024
B. Lynne Parshall Director $4.57M -$6.39M -58.3% Jul 15, 2024
Joseph Baroldi EVP, Chief Business Officer $4.57M -$269K -5.56% Apr 15, 2024
Frederick T. Muto Director $3.44M Jul 15, 2022
Joseph Loscalzo Director $2.49M Jul 15, 2024
Joan E. Herman Director $2.31M Jul 15, 2024
Michael R. Hayden Director $1.98M Jul 1, 2024
Peter N. Reikes Director $1.25M Oct 15, 2021
Joseph Klein III Director $1.18M -$1.05M -47.1% Jul 16, 2024
Allene M. Diaz Director $953K -$81K -7.84% Jul 15, 2024
Michael J. Yang Director $398K Jul 1, 2024
Kyle Jenne EVP, Chf GL Pdt Str Ofcr $68.5K Feb 26, 2024

Recent Insider Transactions by Companies or Individuals for Ionis Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.